TABLE 3.
Mean differences of EQ-5D before and after tuberculosis treatment.
| Study | EQ-5D version | Value set | Active TB | Treated TB | Mean difference | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Patient number | Mean | SD | Patient number | Average | 95% CI | |||
| Awaisu et al. (2012) | EQ-5D-3L | United Kingdom | 0.70 | 0.31 | 46 | 0.91 | 0.14 | 46 | 0.21 | 0.11–0.31 |
| Kittikraisak et al. (2012) | EQ-5D-3L | Thai | 0.69 | 0.22 | 32 | 0.88 | 0.17 | 32 | 0.19 | 0.09–0.29 |
| Kastien-Hilka et al. (2017) | EQ-5D-5L | United Kingdom | 0.505 | 0.328 | 129 | 0.980 | 0.328 a | 129 | 0.47 | 0.35–0.60 |
| Zimbabwe | 0.620 | 0.203 | 129 | 0.893 | 0.203 a | 129 | 0.27 | 0.22–0.32 | ||
| Saleem et al. (2018) | EQ-5D-3L | United Kingdom | 0.43 | 0.37 | 226 | 0.88 | 0.11 | 176 | 0.45 | 0.40–0.50 |
SD, standard deviation; TB, tuberculosis.
Assumed the same value as the SD of active TB.